The routinization of intraperitoneal (intracavitary) chemotherapy and immunotherapy.
Regelson
W
W
Parker
G
G
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007167:Immunotherapy; D066298:In Vitro Techniques; D007263:Infusions, Parenteral; D008727:Methotrexate / Q000008:administration & dosage; D010289:Parenteral Nutrition, Total; D010529:Peritoneal Cavity; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000970:Antineoplastic Agents; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate